GridAI Technologies Corp.
About GridAI Technologies Corp.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $36.3K
- Net income
- -$6.4M
- Total assets
- $48.6M
- Market cap
- $42.2M
- Gross margin
- -1813.6%
- Operating margin
- -19540.0%
- Net margin
- -18078.3%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $36.3K
- Cost of revenue
- $693.7K
- Gross profit
- -$657.4K
- Operating expenses
- $6.4M
- Operating income
- -$7.1M
- Income tax
- -$398.7K
- Net income
- -$6.6M
- EPS (basic)
- $-4.16
- EPS (diluted)
- $-4.16
Balance sheet
- Total assets
- $48.6M
- Current assets
- $2.6M
- Total liabilities
- $19.7M
- Current liabilities
- $15.2M
- Shareholders’ equity
- $24.9M
Cash flow
- Operating cash flow
- -$5.7M
- Investing cash flow
- $323.5K
- Financing cash flow
- $5.9M
- Net cash flow
- $714.8K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $42.2M
- EPS (diluted)
- $-4.16
- Shares outstanding
- 6.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 11, 2016
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $6.4M in FY2025.
- Gross margin of -1813.6%, net margin -18078.3%.
- Trading 9% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review GridAI Technologies Corp..
